Evidence map›Paper›PMID 27727467›Full record

Trial reportDiabetic medicine : a journal of the British Diabetic Association2017

Glucose challenge test screening for prediabetes and early diabetes.

S L Jackson, S E Safo, L R Staimez, D E Olson, K M V Narayan, Q Long, J Lipscomb, M K Rhee, P W F Wilson, A M Tomolo and 1 more

Abstract readClinical Trial
In one paragraph

Trial report in Diabetic medicine : a journal of the British Diabetic Association, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 26 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Alternative type 2 diabetes screening tests may reduce the number of U.S. adults with undiagnosed diabetes.Diabetic medicine : a journal of the British Diabetic Association · 2020
    Article
  7. Article
  8. Review of methods for detecting glycemic disorders.Diabetes research and clinical practice · 2020
    Review
  9. The Oral Glucose Tolerance Test: 100 Years Later.Diabetes, metabolic syndrome and obesity : targets and therapy · 2020
    Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

S L JacksonAtlanta VA Medical Center, Decatur, GA, USA.
S E SafoAtlanta VA Medical Center, Decatur, GA, USA.
L R StaimezDepartment of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
D E OlsonAtlanta VA Medical Center, Decatur, GA, USA.
K M V NarayanDepartment of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
Q LongDepartment of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
J LipscombDepartment of Health Policy and Management, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
M K RheeAtlanta VA Medical Center, Decatur, GA, USA.
P W F WilsonAtlanta VA Medical Center, Decatur, GA, USA.
A M TomoloAtlanta VA Medical Center, Decatur, GA, USA.
L S PhillipsAtlanta VA Medical Center, Decatur, GA, USA.
Emory University · USAtlanta VA Medical Center · US

Funding

Glycemia Reduction Approaches in Diabetes: A comparative effectiveness studyU01DK098246 · NIDDK · GEORGE WASHINGTON UNIVERSITY · PI KRAUSE-STEINRAUF, HEIDI, LACHIN, JOHN M · 2012 to 2022
$238.9M
Atlanta Clinical and Translational Science Institute (ACTSI) RenewalUL1TR000454 · NCATS · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2012 to 2016
$25.8M
Translational Research Core - Engagement and Behavior ChangeP30DK111024 · NIDDK · EMORY UNIVERSITY · PI Mohammed Kumail Ali · 2016 to 2026
$13.4M
Emory University BIRCWH ProgramK12HD085850 · NICHD · EMORY UNIVERSITY · PI OFOTOKUN, IGHOVWERHA, STERK, CLAIRE E · 2015 to 2023
$4.4M
Screening for IGT: Glucose Challenge vs Predictive ModelR18DK066204 · NIDDK · EMORY UNIVERSITY · PI PHILLIPS, LAWRENCE S · 2004 to 2007
$2.9M
Prevention of Cystic Fibrosis DiabetesR01FD003527 · FDA · EMORY UNIVERSITY · PI STECENKO, ARLENE A · 2009 to 2015
$908k
Vitamin D for Type 2 Diabetes (D2D trial)U34DK091958 · NIDDK · TUFTS MEDICAL CENTER · PI PITTAS, ANASTASSIOS G · 2011 to 2012
$792k
Reach, Outcomes and System Impacts of the VA's National Weight Loss Program, MOVER21DK099716 · NIDDK · EMORY UNIVERSITY · PI PHILLIPS, LAWRENCE S · 2014 to 2015
$321k
Prediction of CVD Risk in VeteransI01CX001025 · VA · VETERANS HEALTH ADMINISTRATION · PI CHO, KELLY, WILSON, PETER WYMAN · 2014 to 2025
–
CSRD VA I01 CX001025FDA HHS R01 FD003527NCATS NIH HHS UL1 TR000454NICHD NIH HHS K12 HD085850NIDDK NIH HHS P30 DK111024NIDDK NIH HHS R18 DK066204NIDDK NIH HHS R21 DK099716NIDDK NIH HHS U01 DK098246NIDDK NIH HHS U34 DK091958
6 · The paper itself

Abstract

aimsTo test the hypothesis that a 50-g oral glucose challenge test with 1-h glucose measurement would have superior performance compared with other opportunistic screening methods.

methodsIn this prospective study in a Veterans Health Administration primary care clinic, the following test performances, measured by area under receiver-operating characteristic curves, were compared: 50-g oral glucose challenge test; random glucose; and HbA

resultsThe study population was comprised of 1535 people (mean age 56 years, BMI 30.3 kg/m

conclusionsGlucose challenge test screening, followed, if abnormal, by an oral glucose tolerance test, would be convenient and more accurate than other opportunistic tests. Use of glucose challenge test screening could improve management by permitting earlier therapy.

Indexed as

AdultAgedBlood GlucoseCost-Benefit AnalysisDiabetes Mellitus, Type 2Early DiagnosisFemaleGlucoseGlucose Tolerance TestHumansMaleMass ScreeningMiddle AgedPrediabetic StateROC CurveBlood GlucoseGlucose

Identifiers

PMID27727467
PMCPMC5388592
OpenAlexW2529946920

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.